Shortage of tolmetin sodium

The American Society of Health-System Pharmacists reports a shortage of tolmetin sodium. This drug is used to relieve the symptoms of adult and juvenile rheumatoid arthritis and also osteoarthritis over the short term. There are significant possible side effects, so the lowest dose for the shortest time is desirable. Short-term pain relief is probably its best use, and alternatives should be sought for long-term treatment of these chronic inflammatory conditions.

Shortage of 1% diclofenac gel

The American Society of Health-System Pharmacists reports a shortage of diclofenac in the form of a 1% gel. The US-approved version is made by only one company, Endo, with the brand name Voltaren. No reason for the shortage is given. This gel is applied to joints in the hands, wrists, elbows, knees, ankles, or feet to relieve the pain due to loss of joint cartilage and the underlying bone most common from middle age onward, aka osteoarthritis. There are various reasons to avoid taking diclofenac by mouth. If your doctor agrees, a compounding pharmacy can make the gel from the diclofenac contained in capsules.